Author

Ryo Numazawa

Sapporo Medical UniversityORCID 0009-0002-7238-1589Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Atsushi KunoiD· 1 shared Hori Tomoki· 1 shared Iyori Nojima· 1 shared Keiji SaitoiD· 1 shared Koki AbeiD· 1 shared Ryusuke HosodaiD· 1 shared Tatsuya SatoiD· 1 shared Yuki TatekoshiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Atsushi KunoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintAug 3, 2026

Activation of the NAD⁺-Sirtuin Axis Protects Against Chronic Doxorubicin-Induced Subclinical Renal Tubular Injury Through Restoration of Mitochondrial Homeostasis and Suppression of Inflammation

Keiji Saito, Ryusuke Hosoda, Ryo Numazawa…·Atsushi Kuno

This study shows that chronic low-dose doxorubicin causes mitochondrial dysfunction and inflammation in renal tubules, which can be mitigated by activating the NAD⁺-Sirtuin axis with resveratrol or NMN.

DOI 10.64898/2026.07.29.741470

mouseproteomics

𝕏 PostBluesky